{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:25:33Z","timestamp":1794219933910,"version":"4.8.0"},"reference-count":41,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is characterized by both motor and nonmotor symptoms, including cognitive impairment. Neuronal loss in the nucleus basalis of Meynert (NBM) plays a role in the presentation of cognitive impairment in PD. The implantation of peripheral nerve tissue (PNT) might provide neuroprotective and regenerative capabilities and has shown promising open-label outcomes. The aim of this study was to investigate the safety, feasibility, and clinical outcomes of implanting PNT to the NBM in patients with PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Seven participants with PD underwent bilateral deep brain stimulation (DBS) electrode implantation to the globus pallidus internus plus unilateral PNT regenerating sural nerve graft to the NBM. Participants were monitored at 6-month intervals postoperatively. Clinical outcome measures included neuropsychological, motor, nonmotor, and quality of life ratings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>All participants completed the 6- and 12-month visits and 5 completed the 24-month visit. There were no serious adverse events related to the study intervention. Neuropsychological performance results were similar to those of patients who underwent DBS standard-of-care procedures without graft implantation. Motor and quality of life ratings were slightly worse, with slight improvements in overall nonmotor scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Unilateral implantation of PNT to the NBM was determined as a safe and feasible procedure such that it did not substantially increase the risk for cognitive decline and dementia beyond rates typically observed in late-stage PD. The current study targeted the NBM, an area not associated with motor symptoms, and the mild progression of motor and quality of life ratings suggest that PNT support might have target-specific clinical effects. These findings support the need for further research in this area, including larger studies that use appropriate control groups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2026.3.jns251474","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:01:23Z","timestamp":1786492883000},"page":"1297-1306","source":"Crossref","is-referenced-by-count":0,"title":["Implantation of autologous peripheral nerve tissue to the nucleus basalis of Meynert in patients with Parkinson\u2019s disease during deep brain stimulation surgery: a 2-year report of safety, feasibility, and clinical response"],"prefix":"10.3171","volume":"145","author":[{"given":"Sheliza","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge E.","family":"Quintero","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Kentucky, Lexington;"},{"name":"Neurorestoration Center, University of Kentucky, Lexington;"},{"name":"Department of Neuroscience, University of Kentucky, Lexington, Kentucky;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory","family":"Richert","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Koehl","sequence":"additional","affiliation":[{"name":"Montana Neuropsychological Associates, Missoula, Montana; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia J.","family":"Anderson-Mooney","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Gurwell","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine S.","family":"Manning","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Hulou","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hines","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Slevin","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"},{"name":"Neurorestoration Center, University of Kentucky, Lexington;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg A.","family":"Gerhardt","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"},{"name":"Department of Neurosurgery, University of Kentucky, Lexington;"},{"name":"Neurorestoration Center, University of Kentucky, Lexington;"},{"name":"Department of Neuroscience, University of Kentucky, Lexington, Kentucky;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington;"},{"name":"Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig G.","family":"van Horne","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Kentucky, Lexington;"},{"name":"Neurorestoration Center, University of Kentucky, Lexington;"},{"name":"Department of Neuroscience, University of Kentucky, Lexington, Kentucky;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"8","key":"b1","series-title":"Mov Disord","first-page":"1541","article-title":"The economic impact of cognitive impairment in Parkinson\u2019s disease","volume":"26","author":"Vossius C","year":"2011","unstructured":"Vossius C, Larsen JP, Janvin C, Aarsland D. The economic impact of cognitive impairment in Parkinson\u2019s disease. Mov Disord. 2011;26(8):1541\u20131544. doi:10.1002\/mds.23661"},{"issue":"12","key":"b2","series-title":"Int J Geriatr Psychiatry","first-page":"1362","article-title":"Cognitive impairment in Parkinson\u2019s disease: impact on quality of life of carers","volume":"32","author":"Lawson RA","year":"2017","unstructured":"Lawson RA, Yarnall AJ, Johnston F,  Cognitive impairment in Parkinson\u2019s disease: impact on quality of life of carers. Int J Geriatr Psychiatry. 2017;32(12):1362\u20131370. doi:10.1002\/gps.4623"},{"issue":"2","key":"b3","series-title":"J Neurosurg","first-page":"574","article-title":"Nucleus basalis of Meynert neuronal activity in Parkinson\u2019s disease","volume":"132","author":"Lee DJ","year":"2020","unstructured":"Lee DJ, Milosevic L, Gramer R,  Nucleus basalis of Meynert neuronal activity in Parkinson\u2019s disease. J Neurosurg. 2020;132(2):574\u2013582. doi:10.3171\/2018.11.JNS182386"},{"issue":"6","key":"b4","series-title":"Brain Stimul","first-page":"1643","article-title":"Rethinking NBM DBS: intermittent stimulation improves sustained attention in Parkinson\u2019s disease","volume":"16","author":"Sasikumar S","year":"2023","unstructured":"Sasikumar S, Cohn M, Youm A,  Rethinking NBM DBS: intermittent stimulation improves sustained attention in Parkinson\u2019s disease. Brain Stimul. 2023;16(6):1643\u20131645. doi:10.1016\/j.brs.2023.10.014"},{"issue":"4","key":"b5","series-title":"Acta Neuropathol","first-page":"527","article-title":"Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"129","author":"Liu AKL","year":"2015","unstructured":"Liu AKL, Chang RCC, Pearce RKB, Gentleman SM. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease. Acta Neuropathol. 2015;129(4):527\u2013540. doi:10.1007\/s00401-015-1392-5"},{"issue":"5","key":"b6","series-title":"Brain","first-page":"1501","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease","volume":"141","author":"Schulz J","year":"2018","unstructured":"Schulz J, Pagano G, Fern\u00e1ndez Bonfante JA, Wilson H, Politis M. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson\u2019s disease. Brain. 2018;141(5):1501\u20131516. doi:10.1093\/brain\/awy072"},{"issue":"1","key":"b7","series-title":"Nat Rev Dis Primers","first-page":"47","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland D","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM,  Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers. 2021;7(1):47. doi:10.1038\/s41572-021-00280-3"},{"issue":"10","key":"b8","series-title":"Mov Disord","first-page":"1814","article-title":"MDS task force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI","volume":"26","author":"Litvan I","year":"2011","unstructured":"Litvan I, Aarsland D, Adler CH,  MDS task force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI. Mov Disord. 2011;26(10):1814\u20131824. doi:10.1002\/mds.23823"},{"issue":"6","key":"b9","series-title":"Ann Neurol","first-page":"715","article-title":"Clinical progression in Parkinson disease and the neurobiology of axons","volume":"67","author":"Cheng HC","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE. Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol. 2010;67(6):715\u2013725. doi:10.1002\/ana.21995"},{"issue":"Pt 10","key":"b10","series-title":"Brain","first-page":"2191","article-title":"Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys","volume":"125","author":"Grondin R","year":"2002","unstructured":"Grondin R, Zhang Z, Yi A,  Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain. 2002;125(Pt 10):2191-2201. doi:10.1093\/brain\/awf234"},{"issue":"8064","key":"b11","series-title":"Nature","first-page":"978","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease","volume":"641","author":"Tabar V","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM,  Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature. 2025;641(8064):978\u2013983. doi:10.1038\/s41586-025-08845-y"},{"key":"b12","series-title":"Regen Ther","first-page":"18","article-title":"iPS cell-based therapy for Parkinson\u2019s disease: a Kyoto trial","volume":"13","author":"Takahashi J","year":"2020","unstructured":"Takahashi J. iPS cell-based therapy for Parkinson\u2019s disease: a Kyoto trial. Regen Ther. 2020;13:18\u201322. doi:10.1016\/j.reth.2020.06.002"},{"issue":"8064","key":"b13","series-title":"Nature","first-page":"971","article-title":"Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease","volume":"641","author":"Sawamoto N","year":"2025","unstructured":"Sawamoto N, Doi D, Nakanishi E,  Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature. 2025;641(8064):971\u2013977. doi:10.1038\/s41586-025-08700-0"},{"issue":"9","key":"b14","series-title":"Nat Rev Neurol","first-page":"492","article-title":"Cell-based therapies for Parkinson disease-past insights and future potential","volume":"11","author":"Barker RA","year":"2015","unstructured":"Barker RA, Drouin-Ouellet J, Parmar M. Cell-based therapies for Parkinson disease-past insights and future potential. Nat Rev Neurol. 2015;11(9):492\u2013503. doi:10.1038\/nrneurol.2015.123"},{"key":"b15","series-title":"Cell Transplant","first-page":"9636897221123515","article-title":"Using a transection paradigm to enhance the repair mechanisms of an investigational human cell therapy","volume":"31","author":"Chau MJ","year":"2022","unstructured":"Chau MJ, Quintero JE, Monje PV,  Using a transection paradigm to enhance the repair mechanisms of an investigational human cell therapy. Cell Transplant. 2022;31:9636897221123515. doi:10.1177\/09636897221123515"},{"issue":"4","key":"b16","series-title":"J Neurosurg","first-page":"1140","article-title":"Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson\u2019s disease treated with bilateral STN DBS: a report of safety and feasibility","volume":"126","author":"van Horne CG","year":"2017","unstructured":"van Horne CG, Quintero JE, Gurwell JA, Wagner RP, Slevin JT, Gerhardt GA. Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson\u2019s disease treated with bilateral STN DBS: a report of safety and feasibility. J Neurosurg. 2017;126(4):1140\u20131147. doi:10.3171\/2016.2.JNS151988"},{"issue":"2","key":"b17","series-title":"BMJ Neurol Open","first-page":"e000301","article-title":"Direct delivery of an investigational cell therapy in patients with Parkinson\u2019s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design","volume":"4","author":"Quintero JE","year":"2022","unstructured":"Quintero JE, Slevin JT, Gurwell JA,  Direct delivery of an investigational cell therapy in patients with Parkinson\u2019s disease: an interim analysis of feasibility and safety of an open-label study using DBS-Plus clinical trial design. BMJ Neurol Open. 2022;4(2):e000301. doi:10.1136\/bmjno-2022-000301"},{"issue":"6","key":"b18","series-title":"J Neurosurg","first-page":"1550","article-title":"Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson\u2019s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome","volume":"129","author":"van Horne CG","year":"2018","unstructured":"van Horne CG, Quintero JE, Slevin JT,  Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson\u2019s disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome. J Neurosurg. 2018;129(6):1550\u20131561. doi:10.3171\/2017.8.JNS163222"},{"issue":"2","key":"b19","series-title":"J Parkinsons Dis","first-page":"397","article-title":"Two-year feasibility and safety of open-label autologous peripheral nerve tissue implantation during deep brain stimulation in patients with Parkinson\u2019s disease","volume":"15","author":"Quintero JE","year":"2025","unstructured":"Quintero JE, Chau MJ, Slevin JT,  Two-year feasibility and safety of open-label autologous peripheral nerve tissue implantation during deep brain stimulation in patients with Parkinson\u2019s disease. J Parkinsons Dis. 2025;15(2):397\u2013408. doi:10.1177\/1877718X241312409"},{"issue":"5","key":"b20","series-title":"Nat Med","first-page":"551","article-title":"A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease","volume":"11","author":"Tuszynski MH","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M,  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;11(5):551\u2013555. doi:10.1038\/nm1239"},{"issue":"2","key":"b21","series-title":"J Neurosurg","first-page":"340","article-title":"Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery","volume":"117","author":"Wahlberg LU","year":"2012","unstructured":"Wahlberg LU, Lind G, Almqvist PM,  Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery. J Neurosurg. 2012;117(2):340\u2013347. doi:10.3171\/2012.2.JNS11714"},{"issue":"19","key":"b22","series-title":"J Clin Med","first-page":"6121","article-title":"Recipient reaction and composition of autologous sural nerve tissue grafts into the human brain","volume":"12","author":"Colvett I","year":"2023","unstructured":"Colvett I, Gilmore A, Guzman S,  Recipient reaction and composition of autologous sural nerve tissue grafts into the human brain. J Clin Med. 2023;12(19):6121. doi:10.3390\/jcm12196121"},{"issue":"2","key":"b23","series-title":"J Comp Neurol","first-page":"216","article-title":"Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase","volume":"275","author":"Mesulam MM","year":"1988","unstructured":"Mesulam MM, Geula C. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol. 1988;275(2):216\u2013240. doi:10.1002\/cne.902750205"},{"issue":"2","key":"b24","series-title":"Ann Neurol","first-page":"163","article-title":"The nucleus basalis of Meynert in neurological disease: a quantitative morphological study","volume":"17","author":"Rogers JD","year":"1985","unstructured":"Rogers JD, Brogan D, Mirra SS. The nucleus basalis of Meynert in neurological disease: a quantitative morphological study. Ann Neurol. 1985;17(2):163\u2013170. doi:10.1002\/ana.410170210"},{"key":"b25","series-title":"Front Hum Neurosci","first-page":"645584","article-title":"Case report: deep brain stimulation of the nucleus basalis of Meynert for advanced Alzheimer\u2019s disease","volume":"15","author":"Zhang W","year":"2021","unstructured":"Zhang W, Liu W, Patel B,  Case report: deep brain stimulation of the nucleus basalis of Meynert for advanced Alzheimer\u2019s disease. Front Hum Neurosci. 2021;15:645584. doi:10.3389\/fnhum.2021.645584"},{"issue":"5-6","key":"b26","series-title":"Commun Integr Biol","first-page":"e1389359","article-title":"Potential for intermittent stimulation of nucleus basalis of Meynert to impact treatment of Alzheimer\u2019s disease","volume":"10","author":"Blake DT","year":"2017","unstructured":"Blake DT, Terry AV, Plagenhoef M, Constantinidis C, Liu R. Potential for intermittent stimulation of nucleus basalis of Meynert to impact treatment of Alzheimer\u2019s disease. Commun Integr Biol. 2017;10(5-6):e1389359. doi:10.1080\/19420889.2017.1389359"},{"issue":"4","key":"b27","series-title":"Neuropsychol Rev","first-page":"439","article-title":"Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson\u2019s disease: a meta-analysis","volume":"25","author":"Combs HL","year":"2015","unstructured":"Combs HL, Folley BS, Berry DTR,  Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson\u2019s disease: a meta-analysis. Neuropsychol Rev. 2015;25(4):439\u2013454. doi:10.1007\/s11065-015-9302-0"},{"key":"b28","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013","unstructured":"Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association Publishing; 2013."},{"key":"b29","series-title":"Recent Developments in Parkinsons Disease","first-page":"153","article-title":"Unified Parkinsons Disease Rating Scale","volume":"Vol 2","author":"Fahn S","year":"1987","unstructured":"Fahn S, Elton R. Unified Parkinsons Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent Developments in Parkinsons Disease. Vol 2. Macmillan Healthcare Information; 1987:153\u2013163."},{"issue":"13","key":"b30","series-title":"Mov Disord","first-page":"1901","article-title":"The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study","volume":"22","author":"Chaudhuri KR","year":"2007","unstructured":"Chaudhuri KR, Martinez-Martin P, Brown RG,  The metric properties of a novel non-motor symptoms scale for Parkinson\u2019s disease: results from an international pilot study. Mov Disord. 2007;22(13):1901\u20131911. doi:10.1002\/mds.21596"},{"issue":"6","key":"b31","series-title":"Psychol Health","first-page":"805","article-title":"The PDQ-8: development and validation of a short-form Parkinson\u2019s disease questionnaire","volume":"12","author":"Jenkinson C","year":"1997","unstructured":"Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman  N. The PDQ-8: development and validation of a short-form Parkinson\u2019s disease questionnaire. Psychol Health. 1997;12(6):805\u2013814. doi:10.1080\/08870449708406741"},{"issue":"15","key":"b32","series-title":"Mov Disord","first-page":"2649","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson CL","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord. 2010;25(15):2649\u20132653. doi:10.1002\/mds.23429"},{"issue":"7","key":"b33","series-title":"Mov Disord","first-page":"974","article-title":"Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson\u2019s disease","volume":"22","author":"Aybek S","year":"2007","unstructured":"Aybek S, Gronchi-Perrin A, Berney A,  Long-term cognitive profile and incidence of dementia after STN-DBS in Parkinson\u2019s disease. Mov Disord. 2007;22(7):974\u2013981. doi:10.1002\/mds.21478"},{"issue":"10 Pt 2","key":"b34","series-title":"Neurosci Biobehav Rev","first-page":"2676","article-title":"The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia?","volume":"37","author":"Gratwicke J","year":"2013","unstructured":"Gratwicke J, Kahan J, Zrinzo L,  The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia? Neurosci Biobehav Rev. 2013;37(10 Pt 2):2676\u20132688. doi:10.1016\/j.neubiorev.2013.09.003"},{"issue":"2","key":"b35","series-title":"JAMA Neurol","first-page":"169","article-title":"Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson disease dementia a randomized clinical trial","volume":"75","author":"Gratwicke J","year":"2018","unstructured":"Gratwicke J, Zrinzo L, Kahan J,  Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson disease dementia a randomized clinical trial. JAMA Neurol. 2018;75(2):169\u2013178. doi:10.1001\/jamaneurol.2017.3762"},{"issue":"8","key":"b36","series-title":"Brain","first-page":"2490","article-title":"Natural history of motor symptoms in Parkinson\u2019s disease and the long-duration response to levodopa","volume":"143","author":"Cilia R","year":"2020","unstructured":"Cilia R, Cereda E, Akpalu A,  Natural history of motor symptoms in Parkinson\u2019s disease and the long-duration response to levodopa. Brain. 2020;143(8):2490\u20132501. doi:10.1093\/brain\/awaa181"},{"key":"b37","series-title":"Hopkins Verbal Learning Test-Revised","author":"Brandt J","year":"2001","unstructured":"Brandt J, Benedict RHB. Hopkins Verbal Learning Test-Revised. Psychological Assessment Resources; 2001."},{"key":"b38","series-title":"Wechsler Memory Scale","author":"Wechsler D","year":"2009","unstructured":"Wechsler D. Wechsler Memory Scale. 4th ed. Pearson; 2009."},{"key":"b39","series-title":"Contributions to Neuropsychological Assessment","author":"Benton AL","year":"1994","unstructured":"Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to Neuropsychological Assessment. 2nd ed. Oxford University Press; 1994."},{"key":"b40","series-title":"The Stroop Color and Word Test: A Manual for Clinical and Experimental Uses","author":"Golden CJ","year":"2002","unstructured":"Golden CJ, Freshwater SM. The Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Stoelting Co; 2002."},{"key":"b41","series-title":"WAIS-IV Technical and Interpretive Manual","author":"Wechsler D","year":"2008","unstructured":"Wechsler D. WAIS-IV Technical and Interpretive Manual. Psychological Corp; 2008."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/145\/5\/article-p1297.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/145\/5\/article-p1297.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/145\/5\/article-p1297.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:59:59Z","timestamp":1794218399000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/145\/5\/article-p1297.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11,1]]},"references-count":41,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.3171\/2026.3.jns251474","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11,1]]}}}